In vitro characterization of commercial factor VIII concentrates: Long-term follow-up
- 1 July 1984
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 49 (1) , 53-59
- https://doi.org/10.1007/bf00320384
Abstract
Fifty batches of Factor VIII concentrates from 12 producers were characterized in a long-term follow-up. The following parameters were measured: Factor VIII:C, Factor VIIIR:AG, Factor VIII:Rcof, specific activity (U Factor VIII:C/mg protein), fibrinogen, IgG, IgM, IgA, isoagglutinins, Hbs-AG, heparin-like activity, thrombin-like activity, antithrombin III, Factor VIII-stability at room temperature, and the rate of complete dissolution of the lyophilizate. In most preparations there was an unacceptable batch-to-batch variation of both Factor VIII complex and contaminating proteins, which exceeded the inter-assay coefficient of variation of the applied test systems. Nevertheless, different brands could be recognized by their typical protein pattern. The results obtained suggest that the standardization of Factor VIII concentrates of unknown composition is still accompanied by considerable risks.Keywords
This publication has 9 references indexed in Scilit:
- [Factor VIII concentrates. Problems and protein chemistry characterization].1982
- [Side-effects of factor VIII substitution in patients with hemophilia A (author's transl)].1982
- FACTOR VIII STANDARDISATIONThe Lancet, 1981
- FACTOR VIII CONCENTRATES: WHAT THE LABEL SAYSThe Lancet, 1981
- Standardization of Factor VIII I. CALIBRATION OF BRITISH STANDARDS FOR FACTOR VIII CLOTTING ACTIVITYBritish Journal of Haematology, 1980
- Characteristics of Various Factor VIII Concentrates used in Treatment of Haemophilia ABritish Journal of Haematology, 1977
- Hemolysis Caused by Factor VIII ConcentratesArchives of internal medicine (1960), 1976
- Hemolytic Anemia Due to Anti‐A in Concentrated Antihemophilic Factor PreparationsTransfusion, 1970